Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB25FSZ26
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $82,042
Award facts
- Contract value 100% obligated
- $82,041.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded on August 20, 2025, by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., covers the supply of Keytruda 100 mg/4 mL vials with a ceiling value of $82,041.50 and an ultimate completion date of September 11, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery will be performed in Park Ridge, Illinois, utilizing a firm fixed-price contract structure under the existing Indefinite Delivery Contract (IDC) vehicle with the DLA's SPE2DB program, which is valued at approximately $500 million and remains valid through November 2026.
Keytruda is a leading oncology immunotherapy medication used in cancer treatment, and this award reflects DMS Pharmaceutical Group's established role as a critical supplier within the federal pharmaceutical supply chain. The company's selection demonstrates its capability to deliver specialized pharmaceutical products directly to Department of Defense healthcare facilities. DMS Pharmaceutical Group maintains a robust portfolio of federal contracts with the DLA, regularly supplying branded and generic prescription drugs, biologics, and medical consumables to military health installations nationwide, positioning the company as a key vendor for pharmaceutical distribution to the defense medical system.
Quick answers
Who was awarded contract SPE2DB25FSZ26?
SPE2DB25FSZ26 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 20, 2025.
How much is contract SPE2DB25FSZ26 worth?
The government has obligated $82,042 on SPE2DB25FSZ26.
Is contract SPE2DB25FSZ26 an order under another contract?
Yes. SPE2DB25FSZ26 is a delivery order under SPE2DB22D9367, an indefinite delivery contract.
Was contract SPE2DB25FSZ26 competed?
The extent of competition for SPE2DB25FSZ26 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award